Centogene B V Stock Short Ratio
| CNTG Stock | USD 0.09 0.02 14.09% |
Centogene B V fundamentals help investors to digest information that contributes to Centogene's financial success or failures. It also enables traders to predict the movement of Centogene Stock. The fundamental analysis module provides a way to measure Centogene's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Centogene stock.
Centogene | Short Ratio |
Centogene B V Company Short Ratio Analysis
Centogene's Short Ratio is typically used by traders and speculators to identify trends in current market sentiment for a particular equity instrument. In its simple terms this ratio shows how many days it will take all current short sellers to cover their positions if the price of a stock begins to rise.
Current Centogene Short Ratio | 0.82 X |
Most of Centogene's fundamental indicators, such as Short Ratio, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Centogene B V is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Centogene Short Ratio Driver Correlations
Understanding the fundamental principles of building solid financial models for Centogene is extremely important. It helps to project a fair market value of Centogene Stock properly, considering its historical fundamentals such as Short Ratio. Since Centogene's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Centogene's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Centogene's interrelated accounts and indicators.
Click cells to compare fundamentals
The higher the Short Ratio, the longer it would take to buy back the borrowed shares. In theory, the more short positions are currently outstanding, the faster it will be to cover shorted positions.
| Competition |
Centogene Discontinued Operations
Discontinued Operations |
|
Based on the latest financial disclosure, Centogene B V has a Short Ratio of 0.82 times. This is 78.97% lower than that of the Health Care Providers & Services sector and 85.91% lower than that of the Health Care industry. The short ratio for all United States stocks is 79.5% higher than that of the company.
Centogene Short Ratio Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Centogene's direct or indirect competition against its Short Ratio to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Centogene could also be used in its relative valuation, which is a method of valuing Centogene by comparing valuation metrics of similar companies.Centogene is currently under evaluation in short ratio category among its peers.
Centogene Current Valuation Drivers
We derive many important indicators used in calculating different scores of Centogene from analyzing Centogene's financial statements. These drivers represent accounts that assess Centogene's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Centogene's important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 147.3M | 184.4M | 103.2M | 23.3M | 30.6M | 29.0M | |
| Enterprise Value | 137.7M | 165.4M | 112.6M | 51.4M | 91.9M | 173.6M |
Centogene Institutional Holders
Institutional Holdings refers to the ownership stake in Centogene that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Centogene's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Centogene's value.| Shares | Apollon Wealth Management, Llc | 2024-06-30 | 0.0 | Morgan Stanley - Brokerage Accounts | 2024-09-30 | 0.0 | Scoggin Llc | 2024-06-30 | 0.0 | Geode Capital Management, Llc | 2024-06-30 | 0.0 | Jpmorgan Chase & Co | 2024-09-30 | 0.0 | Meeder Asset Management Inc | 2024-06-30 | 0.0 | Xtx Topco Ltd | 2024-09-30 | 0.0 | Hrt Financial Llc | 2024-09-30 | 0.0 | Blackrock Inc | 2024-06-30 | 18.3 K | Barclays Plc | 2024-09-30 | 15.3 K | Virtu Financial Llc | 2024-06-30 | 13.8 K |
Centogene Fundamentals
| Return On Equity | -13.75 | ||||
| Return On Asset | -0.27 | ||||
| Profit Margin | (0.73) % | ||||
| Operating Margin | (0.63) % | ||||
| Current Valuation | 68.28 M | ||||
| Shares Outstanding | 29 M | ||||
| Shares Owned By Insiders | 4.56 % | ||||
| Shares Owned By Institutions | 66.89 % | ||||
| Number Of Shares Shorted | 81.71 K | ||||
| Price To Earning | (6.69) X | ||||
| Price To Book | 0.86 X | ||||
| Price To Sales | 0.19 X | ||||
| Revenue | 47.54 M | ||||
| Gross Profit | 35.9 M | ||||
| EBITDA | (30.87 M) | ||||
| Net Income | (34.8 M) | ||||
| Cash And Equivalents | 42.67 M | ||||
| Cash Per Share | 1.58 X | ||||
| Total Debt | 80.41 M | ||||
| Debt To Equity | 1.31 % | ||||
| Current Ratio | 2.48 X | ||||
| Book Value Per Share | (0.87) X | ||||
| Cash Flow From Operations | (36.96 M) | ||||
| Short Ratio | 0.82 X | ||||
| Earnings Per Share | (1.39) X | ||||
| Target Price | 1.52 | ||||
| Number Of Employees | 384 | ||||
| Beta | -0.67 | ||||
| Market Capitalization | 9.43 M | ||||
| Total Asset | 77.22 M | ||||
| Retained Earnings | (177.36 M) | ||||
| Working Capital | 653 K | ||||
| Current Asset | 57.14 M | ||||
| Current Liabilities | 30.14 M | ||||
| Net Asset | 77.22 M |
About Centogene Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Centogene B V's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Centogene using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Centogene B V based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
When determining whether Centogene B V is a strong investment it is important to analyze Centogene's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Centogene's future performance. For an informed investment choice regarding Centogene Stock, refer to the following important reports:Check out Centogene Piotroski F Score and Centogene Altman Z Score analysis. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Centogene. If investors know Centogene will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Centogene listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.39) | Revenue Per Share 1.723 | Quarterly Revenue Growth (0.08) | Return On Assets (0.27) | Return On Equity (13.75) |
The market value of Centogene B V is measured differently than its book value, which is the value of Centogene that is recorded on the company's balance sheet. Investors also form their own opinion of Centogene's value that differs from its market value or its book value, called intrinsic value, which is Centogene's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Centogene's market value can be influenced by many factors that don't directly affect Centogene's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Centogene's value and its price as these two are different measures arrived at by different means. Investors typically determine if Centogene is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Centogene's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.